Main Content

Press Release


ELEKTA CAPITAL MARKETS DAY IN NEW YORK ON MARCH 15, 2006

Invitation/reminder
Stockholm, February 28, 2006

Following Elekta’s release of its 9 months report (on March 8), you are invited to a Capital Markets Day in New York on Wednesday, March 15, in Scandinavia House at 58 Park Avenue.

Tomas Puusepp, President and CEO of Elekta will present and discuss Elekta’s result for the first nine months of fiscal year 2005/06 and also together with Lars Jonsteg, VP Investor Relations Elekta North America, review market developments, product strategies and progress from the integration of IMPAC Medical Systems and Medical Intelligence.

When?
Wednesday, March 15, 10:00am – 1:00pm

Where?
Scandinavia House, 58 Park Avenue at 38th Street

How?
From 9:45 we will serve a “Swedish” continental breakfast.
The presentations will start at 10:00 until noon.
At 12 noon we will serve a Swedish Smörgåsbord.


We would appreciate your response to this invitation no later than March 1. Please e-mail to: lars.jonsteg@elekta.com or tel. +1 678 427 7951.

Most welcome to an informative event!

Best regards


Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel. +46 8 587 254 99, e-mail: peter.ejemyr@elekta.com

******

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 1700 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.


This information was brought to you by Waymaker http://www.waymaker.net